Division of Pediatric Endocrinology and Diabetes, Children's Hospital at Montefiore, Albert Einstein School of Medicine, Bronx, New York, USA,
Division of Pediatric Endocrinology, Baystate Children's Hospital, Springfield, Massachusetts, USA.
Horm Res Paediatr. 2020;93(6):343-350. doi: 10.1159/000513060. Epub 2021 Jan 22.
Pediatric endocrine practices had to rapidly transition to telemedicine care at the onset of the novel coronavirus disease 2019 (COVID-19) pandemic. For many, it was an abrupt introduction to providing virtual healthcare, with concerns related to quality of patient care, patient privacy, productivity, and compensation, as workflows had to change.
The review summarizes the common adaptations for telemedicine during the pandemic with respect to the practice of pediatric endocrinology and discusses the benefits and potential barriers to telemedicine. Key Messages: With adjustments to practice, telemedicine has allowed providers to deliver care to their patients during the COVID-19 pandemic. The broader implementation of telemedicine in pediatric endocrinology practice has the potential for expanding patient access. Research assessing the impact of telemedicine on patient care outcomes in those with pediatric endocrinology conditions will be necessary to justify its continued use beyond the COVID-19 pandemic.
新型冠状病毒病 2019（COVID-19）大流行开始时，儿科内分泌实践必须迅速过渡到远程医疗护理。对于许多人来说，这是突然引入虚拟医疗保健，与患者护理质量、患者隐私、生产力和补偿有关，因为工作流程必须改变。
本文综述了大流行期间儿科内分泌实践中远程医疗的常见适应方法，并讨论了远程医疗的益处和潜在障碍。
通过调整实践，远程医疗使提供者能够在 COVID-19 大流行期间为患者提供护理。远程医疗在儿科内分泌学实践中的更广泛实施有可能扩大患者的就诊机会。评估远程医疗对儿科内分泌疾病患者护理结果的影响的研究将是必要的，以证明其在 COVID-19 大流行之外的持续使用是合理的。
